20 April 2021

GSK Stockmann in Luxembourg recognized as a leading firm by The Legal 500 EMEA 2021

The Legal 500 Europe, Middle East and Africa (EMEA) has published its rankings for 2021 and recognizes GSK Stockmann in Luxembourg as a leading firm based on its annual survey of the legal services market.

The recognized categories are:

  • Banking, Finance and Capital Markets
  • Investment Funds
  • Tax

While the ranking positions for “Banking, Finance and Capital Markets” as well as “Investment Funds” were improved, the practice area “Tax” entered the rankings for the first time. In addition, Andreas Heinzmann, Partner at GSK Stockmann in Luxembourg, is recognized as “Leading Individual” for “Banking, Finance and Capital Markets”. The full details of the editorials for The Legal500 EMEA 2021 rankings are available here.

Based on its ongoing development, GSK Stockmann in Luxembourg has been strengthening its ranking position since its inception in 2016. A sincere thanks goes to all clients for their ongoing trust and all members of the practice areas highlighted in the rankings for their hard work and efforts.

The Legal 500 EMEA guide provides researched coverage of over 80 countries and over 2,700 ranked law firms. Law firms pay nothing to participate and ranking decisions are based on merit alone. The research process is conducted annually, providing a detailed qualitative assessment of various factors including work conducted by law firms over the past 12 months and historically; experience and depth of teams; specialisms and ancillary services; and, opinions of law firms’ clients.


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
© GSK Stockmann 2024